AERA Pediatrics Registry
NCT07071298 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2026-07-07
Summary
Prospective, multi-center, observational, real-world evidence data collection registry to confirm the continued clinical performance of the AERA® device in pediatric patients
Conditions
- Dysfunction of Eustachian Tube
Sponsors & Collaborators
-
Integra LifeSciences Corporation
lead INDUSTRY
Principal Investigators
-
Christopher Schutt, MD · Acclarent, an Integra LifeSciences Company
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-17
- Primary Completion
- 2030-10-31
- Completion
- 2031-02-28
Countries
- United States
Study Locations
More Related Trials
-
The Prevalence and Clinical Characteristics of Children With Local Allergic Rhinitis
NCT02271620 ·Status: COMPLETED ·Phase: NA
-
Allergy UK Research and Development Nurse Project
NCT03826953 ·Status: COMPLETED ·Phase: NA
-
Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases
NCT05334940 ·Status: RECRUITING
-
A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients
NCT06441812 ·Status: RECRUITING ·Phase: PHASE2
-
A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics
NCT00116883 ·Status: COMPLETED ·Phase: PHASE3
-
Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.
NCT02230475 ·Status: COMPLETED
-
A Novel Biologic Therapy for Perennial Allergic Rhinitis
NCT03360071 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of Perennial Allergic Rhinitis In Pediatrics
NCT00253058 ·Status: COMPLETED ·Phase: PHASE3
-
Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies
NCT01307319 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders
NCT00557895 ·Status: TERMINATED
-
Application of Ectoine Containing Nasal Spray and Eye Drops in Patients With Allergic Rhinitis
NCT02131051 ·Status: COMPLETED
-
e-ITAG Allergen Immunotherapy in the Management of Allergic Asthma
NCT06021912 ·Status: UNKNOWN
-
International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis
NCT02041624 ·Status: TERMINATED
-
A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment
NCT05560698 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine
NCT03755713 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils
NCT04538937 ·Status: RECRUITING
-
A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance
NCT01018693 ·Status: COMPLETED ·Phase: PHASE2
-
Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)
NCT06189742 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice
NCT04038268 ·Status: COMPLETED
-
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
NCT05813288 ·Status: TERMINATED ·Phase: PHASE3
-
Examination of the Role of Atrial Natriuretic Peptide Polymorphisms in Allergic Rhinitis and Asthma Severity
NCT00584051 ·Status: TERMINATED
-
Validation of Proteomic Analyses for Allergic Asthma and Rhinitis
NCT01104012 ·Status: COMPLETED
-
Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand
NCT02000648 ·Status: COMPLETED
-
A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults
NCT00116818 ·Status: COMPLETED ·Phase: PHASE3
-
LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)
NCT00160589 ·Status: COMPLETED ·Phase: PHASE4